eSight 3 Electronic Glasses: A Miracle for the Blind

Related Posts

22Jul

Akston Biosciences Announces Commercial Supply Agreement of Seppic’s Adjuvant to Formulate Akston Shelf-Stable COVID-19 Vaccine at Global Scale

Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, today announced a commercial agreement with Seppic S.A., a... read more
29Feb

EXCLUSIVE: 4 assistive technologies for those with low vision

Roland Mattern, Director of Marketing for eSight by Gentex, discusses some assistive technologies that are enabling people with vision loss... read more
16May

How Wasabi Is Taking On Amazon in the Cloud

Wasabi Technologies, Inc. Chief Executive Officer David Friend discusses how the company is taking on Amazon.com in cloud storage. He... read more
16Aug

New Technology Could Help the Legally Blind to See

Technology being developed at the University of Arizona could help those who are legally blind or who have impaired eyesight... read more
29Dec

Midland’s New Spaceport Aims to Make Space Travel Accessible to All

Drive down a windy, muddy road, hidden on the backside of Midland airport’s southernmost tarmac, and you’ll find a shiny... read more
13Jul

Myomo announces center of excellence program

Myomo Inc., a medical robotics company, has created a new program to partner with O&P clinics in the United States... read more
11Dec

Springfield teen thanks community for help in regaining vision

A Springfield boy hosted a thank you concert for the community who helped him raise funds for his eSight glasses.... read more
20Aug

Technology gives legally blind Peoria boy a chance to fly

National Aviation Day isn’t a widely celebrated occasion, but it will be unforgettable nonetheless for Ryan Rusk. The 12-year-old sixth grader... read more
22Apr

Flight Dynamics Study with the XCOR Lynx using the Suborbital Space Flight Simulator and Mission Control Center

This study was conducted to better understanding of the XCOR Lynx vehicle. Read more >> read more
27Apr

The pandemic changed how Pittsburgh’s life sciences startups get funded

CytoAgents CEO Teresa Whalen, BioHybrid Solutions CEO Jean Pineault and NeuBase Therapeutics CEO Dietrich Stephan agree: COVID-19 radically changed the... read more